Rtw Investments, LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
68
Total Value
6538371722
Accession Number
0001493215-25-000003
Form Type
13F-HR
Manager Name
Rtw Investments, LP
Data Enrichment
93% identified
63 identified5 unidentified

Holdings

68 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
Zai Lab Ltd
Shares:
3136680(+25.0%)
Value:
$113.4B(+72.5%)
CYTOKINETICS INC
Shares:
2721158(+0.0%)
Value:
$109.4B(-14.6%)
ESTABLISHMENT LABS HOLDINGS INC.
Shares:
2583887(+0.6%)
Value:
$105.4B(-10.9%)
Apogee Therapeutics, Inc.
Shares:
2712097(+0.0%)
Value:
$101.3B(-17.5%)
INTUITIVE SURGICAL INC
Shares:
202456
Value:
$100.3B
GLOBUS MEDICAL INC
Shares:
1125000(+15.7%)
Value:
$82.3B(+2.4%)
Ultragenyx Pharmaceutical Inc.
Shares:
1707402(-13.2%)
Value:
$61.8B(-25.3%)
GH Research PLC
Shares:
5499769(+65.3%)
Value:
$60.7B(+160.5%)
Spyre Therapeutics, Inc.
Shares:
3621996(+0.0%)
Value:
$58.4B(-30.7%)
uniQure N.V.
Shares:
4265428(+372.0%)
Value:
$45.2B(+183.3%)
UroGen Pharma Ltd.
Shares:
3834794(+0.0%)
Value:
$42.4B(+3.8%)
GE HealthCare Technologies Inc.
Shares:
520000
Value:
$42.0B
CG Oncology, Inc.
Shares:
1701216(+0.0%)
Value:
$41.7B(-14.6%)
08659B102
Shares:
3299870
Value:
$40.4B
Orchestra BioMed Holdings, Inc.
Shares:
8206162(+0.0%)
Value:
$35.1B(+7.0%)
Stoke Therapeutics, Inc.
Shares:
5123525(+0.0%)
Value:
$34.1B(-39.7%)
Immatics N.V.
Shares:
6909510(+5.6%)
Value:
$31.2B(-33.0%)
Taysha Gene Therapies, Inc.
Shares:
18787866(+116.6%)
Value:
$26.1B(+74.0%)
Verastem, Inc.
Shares:
4245476
Value:
$25.6B
Xencor Inc
Shares:
2402883(+0.0%)
Value:
$25.6B(-53.7%)